BBIO
Price
$26.60
Change
-$1.22 (-4.39%)
Updated
Dec 18, 04:07 PM (EDT)
64 days until earnings call
BPMC
Price
$93.93
Change
-$2.55 (-2.64%)
Updated
Dec 18, 04:07 PM (EDT)
57 days until earnings call
Ad is loading...

BBIO vs BPMC

Header iconBBIO vs BPMC Comparison
Open Charts BBIO vs BPMCBanner chart's image
BridgeBio Pharma
Price$26.60
Change-$1.22 (-4.39%)
Volume$3.54K
CapitalizationN/A
Blueprint Medicines
Price$93.93
Change-$2.55 (-2.64%)
Volume$2.18K
CapitalizationN/A
BBIO vs BPMC Comparison Chart
Loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBIO vs. BPMC commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a Buy and BPMC is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (BBIO: $27.82 vs. BPMC: $96.48)
Brand notoriety: BBIO and BPMC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 73% vs. BPMC: 73%
Market capitalization -- BBIO: $5.26B vs. BPMC: $6.13B
BBIO [@Biotechnology] is valued at $5.26B. BPMC’s [@Biotechnology] market capitalization is $6.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green whileBPMC’s FA Score has 0 green FA rating(s).

  • BBIO’s FA Score: 1 green, 4 red.
  • BPMC’s FA Score: 0 green, 5 red.
According to our system of comparison, BBIO is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 7 TA indicator(s) are bullish while BPMC’s TA Score has 4 bullish TA indicator(s).

  • BBIO’s TA Score: 7 bullish, 3 bearish.
  • BPMC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BBIO is a better buy in the short-term than BPMC.

Price Growth

BBIO (@Biotechnology) experienced а -4.20% price change this week, while BPMC (@Biotechnology) price change was +1.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

BBIO is expected to report earnings on Feb 20, 2025.

BPMC is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($6.13B) has a higher market cap than BBIO($5.26B). BPMC YTD gains are higher at: 4.597 vs. BBIO (-31.087). BPMC has higher annual earnings (EBITDA): -75.58M vs. BBIO (-350.26M). BPMC has more cash in the bank: 734M vs. BBIO (266M). BPMC has less debt than BBIO: BPMC (471M) vs BBIO (1.73B). BPMC has higher revenues than BBIO: BPMC (434M) vs BBIO (218M).
BBIOBPMCBBIO / BPMC
Capitalization5.26B6.13B86%
EBITDA-350.26M-75.58M463%
Gain YTD-31.0874.597-676%
P/E RatioN/AN/A-
Revenue218M434M50%
Total Cash266M734M36%
Total Debt1.73B471M367%
FUNDAMENTALS RATINGS
BPMC: Fundamental Ratings
BPMC
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
70
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIOBPMC
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 6 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 7 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Ad is loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCHJ24.470.01
+0.04%
Schwab 1-5 Year Corporate Bond ETF
IHDG44.58-0.08
-0.18%
WisdomTree Intl Hdgd Qual Div Gr ETF
SIHY46.13-0.27
-0.58%
Harbor Scientific Alpha High-Yield ETF
SEA14.94-0.23
-1.50%
US Global Sea to Sky Cargo ETF
UMDD30.06-1.09
-3.51%
ProShares UltraPro MidCap400

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ARGX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
+0.40%
ARGX - BBIO
46%
Loosely correlated
+0.90%
AXON - BBIO
44%
Loosely correlated
-2.09%
ARRY - BBIO
43%
Loosely correlated
+6.01%
BPMC - BBIO
43%
Loosely correlated
+1.14%
PMN - BBIO
43%
Loosely correlated
-0.64%
More

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
+1.14%
BEAM - BPMC
46%
Loosely correlated
-1.21%
KRYS - BPMC
44%
Loosely correlated
+0.85%
DNLI - BPMC
44%
Loosely correlated
-0.30%
BBIO - BPMC
43%
Loosely correlated
+0.40%
PDSB - BPMC
43%
Loosely correlated
+1.29%
More